You are here

  • Home
  • Archive
  • Volume 11, Issue 5
  • Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial

 

Online download statistics by month:

Online download statistics by month: May 2023 to January 2026

AbstractFullPdf
May 202332232355
Jun 202318418542
Jul 202310410450
Aug 202312412424
Sep 2023848428
Oct 2023767624
Nov 202314114123
Dec 202318618723
Jan 2024434389
Feb 2024646432
Mar 2024444490
Apr 2024585846
May 2024373724
Jun 2024606032
Jul 2024494924
Aug 2024373716
Sep 2024434329
Oct 2024454530
Nov 2024474836
Dec 2024606124
Jan 2025494936
Feb 202510510528
Mar 2025545431
Apr 2025606031
May 2025383830
Jun 2025272722
Jul 2025110
Jan 2026110
Total21432148919